{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T03:22:43Z","timestamp":1792380163085,"version":"4.4.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-AR055952"],"award-info":[{"award-number":["R01-AR055952"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell &amp; Developmental Biology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.semcdb.2015.10.013","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T13:31:29Z","timestamp":1445607089000},"page":"2-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["Mediators of inflammation and bone remodeling in rheumatic disease"],"prefix":"10.1016","volume":"49","author":[{"given":"Anita T.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Gravallese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcdb.2015.10.013_bib0600","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0605","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0610","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2015.10.013_bib0615","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.0105-2896.2005.00325.x","article-title":"Role of ITAM-containing adapter proteins and their receptors in the immune system and bone","volume":"208","author":"Humphrey","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0620","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1084\/jem.20022220","article-title":"Impaired differentiation of osteoclasts in TREM-2-deficient individuals","volume":"198","author":"Cella","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0625","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1172\/JCI16923","article-title":"Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice","volume":"111","author":"Kaifu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0630","doi-asserted-by":"crossref","first-page":"R245","DOI":"10.1186\/ar4088","article-title":"The immunoreceptor tyrosine-based activation motif (ITAM)-related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints","volume":"14","author":"Crotti","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0635","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/ar3380","article-title":"Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis","volume":"13","author":"Braun","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0640","doi-asserted-by":"crossref","first-page":"e18689","DOI":"10.1371\/journal.pone.0018689","article-title":"The critical role of IL-34 in osteoclastogenesis","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semcdb.2015.10.013_bib0645","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jcb.240470313","article-title":"Interleukin 4 inhibits murine osteoclast formation in vitro","volume":"47","author":"Shioi","year":"1991","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0650","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","article-title":"RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta","volume":"416","author":"Takayanagi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2015.10.013_bib0655","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S8756-3282(02)00722-6","article-title":"Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity","volume":"30","author":"Yamada","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.semcdb.2015.10.013_bib0660","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bone.2009.07.079","article-title":"IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo","volume":"45","author":"Yoshimatsu","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.semcdb.2015.10.013_bib0665","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.bbrc.2015.03.033","article-title":"IL-33 inhibits RANKL-induced osteoclast formation through the regulation of Blimp-1 and IRF-8 expression","volume":"460","author":"Kiyomiya","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0670","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/jbmr.269","article-title":"Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells","volume":"26","author":"Schulze","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0675","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.4049\/jimmunol.1003487","article-title":"IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss","volume":"186","author":"Zaiss","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0680","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbrc.2011.11.088","article-title":"Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis","volume":"417","author":"Keller","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0685","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1196\/annals.1346.031","article-title":"Autoimmunity and bone","volume":"1068","author":"Schwarz","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0690","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI1333","article-title":"Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor","volume":"101","author":"Horwood","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0695","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1196\/annals.1346.005","article-title":"BMP and BMP inhibitors in bone","volume":"1068","author":"Rosen","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0700","doi-asserted-by":"crossref","first-page":"29119","DOI":"10.1074\/jbc.M801774200","article-title":"BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation","volume":"283","author":"Matsubara","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0705","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/83810","article-title":"Bone morphogenetic protein-3 is a negative regulator of bone density","volume":"27","author":"Daluiski","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0710","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1359\/jbmr.2003.18.10.1842","article-title":"BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop","volume":"18","author":"Rawadi","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0715","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1136\/ard.2010.132852","article-title":"Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression","volume":"69","author":"Heiland","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0720","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1210\/me.2003-0498","article-title":"The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice","volume":"18","author":"Bodine","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0725","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","article-title":"Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass","volume":"21","author":"Morvan","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0730","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bone.2006.03.017","article-title":"Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia","volume":"39","author":"Li","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.semcdb.2015.10.013_bib0735","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1359\/jbmr.090719","article-title":"Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects","volume":"25","author":"Yao","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0740","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0745","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0750","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nrendo.2011.234","article-title":"MicroRNA control of bone formation and homeostasis","volume":"8","author":"Lian","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0755","doi-asserted-by":"crossref","first-page":"25221","DOI":"10.1074\/jbc.M110.116137","article-title":"miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop","volume":"285","author":"Kapinas","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0760","doi-asserted-by":"crossref","first-page":"15676","DOI":"10.1074\/jbc.M809787200","article-title":"Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation","volume":"284","author":"Li","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0765","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/jbmr.377","article-title":"Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1","volume":"26","author":"Zhang","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0770","doi-asserted-by":"crossref","first-page":"9863","DOI":"10.1073\/pnas.1018493108","article-title":"A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0775","doi-asserted-by":"crossref","first-page":"13906","DOI":"10.1073\/pnas.0804438105","article-title":"A microRNA signature for a BMP2-induced osteoblast lineage commitment program","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0780","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.febslet.2013.07.030","article-title":"miR-145 suppresses osteogenic differentiation by targeting Sp7","volume":"587","author":"Jia","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0785","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/ard.61.12.1047","article-title":"Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis","volume":"61","author":"Crotti","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0790","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0795","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/art.21537","article-title":"Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis","volume":"54","author":"Wong","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0800","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1074\/jbc.M008198200","article-title":"Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways","volume":"276","author":"Zhang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0805","doi-asserted-by":"crossref","first-page":"11846","DOI":"10.1074\/jbc.M512624200","article-title":"Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression","volume":"281","author":"Yao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0810","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1073\/pnas.1010030108","article-title":"TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages","volume":"108","author":"Yarilina","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0815","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/art.23943","article-title":"Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis","volume":"58","author":"Herman","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0820","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2184.2011.00769.x","article-title":"Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells","volume":"44","author":"Huang","year":"2011","journal-title":"Cell Prolif."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0825","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1074\/jbc.M106339200","article-title":"Expression of the osteoblast differentiation factor RUNX2 (Cbfa1\/AML3\/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha","volume":"277","author":"Gilbert","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0830","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/endo.141.11.7739","article-title":"Inhibition of osteoblast differentiation by tumor necrosis factor-alpha","volume":"141","author":"Gilbert","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcdb.2015.10.013_bib0835","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1359\/jbmr.1998.13.5.793","article-title":"Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines","volume":"13","author":"Jilka","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0840","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jbmr.5650020612","article-title":"Interleukin-1 beta is a potent inhibitor of bone formation in vitro","volume":"2","author":"Stashenko","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0845","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0850","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1096\/fasebj.2.15.2903838","article-title":"Skeletal tissue and transforming growth factor beta","volume":"2","author":"Centrella","year":"1988","journal-title":"FASEB J."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0855","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis","volume":"115","author":"Wei","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0860","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1016\/8756-3282(95)00180-L","article-title":"Role of cytokines in bone resorption","volume":"17","author":"Manolagas","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.semcdb.2015.10.013_bib0865","doi-asserted-by":"crossref","first-page":"11535","DOI":"10.1074\/jbc.M607999200","article-title":"Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways","volume":"283","author":"Yoshitake","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0870","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/art.24781","article-title":"Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo","volume":"60","author":"Axmann","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0875","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/1529-0131(199812)41:12<2117::AID-ART6>3.0.CO;2-P","article-title":"Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis","volume":"41","author":"Takagi","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0880","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/annrheumdis-2011-200395","article-title":"Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction","volume":"71","author":"Smolen","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0885","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2015.10.013_bib0890","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biochi.2010.10.001","article-title":"Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts","volume":"93","author":"Zhang","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.semcdb.2015.10.013_bib0895","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/art.10173","article-title":"Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein","volume":"46","author":"Bush","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0900","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9440(10)62961-6","article-title":"Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1","volume":"167","author":"Koenders","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0905","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.20001","article-title":"Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion","volume":"50","author":"Lubberts","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0910","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204782","article-title":"IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis","volume":"74","author":"Adamopoulos","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0915","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/annrheumdis-2012-201601","article-title":"Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study","volume":"72","author":"Genovese","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0920","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.38617","article-title":"A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors","volume":"66","author":"Genovese","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0925","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3899\/jrheum.141271","article-title":"A study to evaluate the safety, tolerability, and efficacy of brodalumab in subjects with rheumatoid arthritis and an inadequate response to methotrexate","volume":"42","author":"Pavelka","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0930","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/art.38896","article-title":"Combined inhibition of tumor necrosis factor alpha and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody","volume":"67","author":"Fischer","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0935","first-page":"7809","article-title":"Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0940","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/ar3693","article-title":"Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis","volume":"14","author":"Hwang","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0945","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/annrheumdis-2011-200096","article-title":"Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients","volume":"71","author":"Chemel","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0950","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.179.5.1517","article-title":"Immunoregulatory role of interleukin 10 in rheumatoid arthritis","volume":"179","author":"Katsikis","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0955","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1529-0131(200101)44:1<3::AID-ANR2>3.0.CO;2-U","article-title":"Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis","volume":"44","author":"van Roon","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0960","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/ar1943","article-title":"Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs","volume":"8","author":"Ideguchi","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0965","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/annrheumdis-2011-201075","article-title":"Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study","volume":"72","author":"Finzel","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0970","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2010.148395","article-title":"Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion","volume":"70","author":"Finzel","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0975","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1359\/jbmr.090320","article-title":"Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis","volume":"24","author":"Walsh","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0980","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.33504","article-title":"Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway","volume":"64","author":"Matzelle","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0985","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0990","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.2008.102046","article-title":"Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints","volume":"69","author":"Uderhardt","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib0995","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/art.39183","article-title":"Brief report: tumor necrosis factor and interleukin-6 differentially regulate Dkk-1 in the inflamed arthritic joint","volume":"67","author":"Yeremenko","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1000","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri1106","article-title":"TREMs in the immune system and beyond","volume":"3","author":"Colonna","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1005","doi-asserted-by":"crossref","first-page":"e0115116","DOI":"10.1371\/journal.pone.0115116","article-title":"Inactivation of DAP12 in PMN inhibits TREM1-mediated activation in rheumatoid arthritis","volume":"10","author":"Chen","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.semcdb.2015.10.013_bib1010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bone.2015.05.029","article-title":"Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) mediates periarticular bone loss, but not joint destruction, in murine antigen-induced arthritis","volume":"79","author":"Shimizu","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.semcdb.2015.10.013_bib1015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08916930701694469","article-title":"Taking a toll on the bones: regulation of bone metabolism by innate immune regulators","volume":"41","author":"Bar-Shavit","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semcdb.2015.10.013_bib1020","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.4049\/jimmunol.170.7.3688","article-title":"Lipopolysaccharide promotes the survival of osteoclasts via toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages","volume":"170","author":"Itoh","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1025","doi-asserted-by":"crossref","DOI":"10.1096\/fj.15-272559","article-title":"TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss","author":"Kassem","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4049\/jimmunol.1102977","article-title":"TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-alpha levels","volume":"189","author":"Chamberlain","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1035","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1073\/pnas.1019536108","article-title":"MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis","volume":"108","author":"Kurowska-Stolarska","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1040","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","article-title":"Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1045","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/art.30281","article-title":"Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice","volume":"63","author":"Bluml","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.humimm.2009.11.008","article-title":"miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis","volume":"71","author":"Fulci","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1055","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1074\/jbc.M805777200","article-title":"Impaired micro-RNA pathways diminish osteoclast differentiation and function","volume":"284","author":"Sugatani","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1060","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1002\/art.34550","article-title":"Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1065","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/art.30321","article-title":"The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis","volume":"63","author":"Nakasa","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni.1698","article-title":"The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo","volume":"10","author":"McGeachy","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","article-title":"Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis","volume":"30","author":"Mei","year":"2011","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1080","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00296-010-1769-7","article-title":"Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis","volume":"32","author":"Duan","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1085","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.37937","article-title":"In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis","volume":"65","author":"Appel","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1090","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","article-title":"Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response","volume":"13","author":"Appel","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1095","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/art.23655","article-title":"Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides","volume":"58","author":"Jandus","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1100","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/art.38376","article-title":"Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression","volume":"66","author":"Menon","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcma.2012.05.006","article-title":"Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis","volume":"75","author":"Chen","year":"2012","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1110","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00296-010-1655-3","article-title":"Increased plasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings","volume":"32","author":"Andersen","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2005.037465","article-title":"Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases","volume":"65","author":"Francois","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","article-title":"Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis","volume":"38","author":"Braun","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1125","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/03009742.2014.956142","article-title":"Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study","volume":"44","author":"Sveaas","year":"2015","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1130","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1135","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.4238\/2014.June.18.10","article-title":"IL-23 promotes osteoclastogenesis in osteoblast-osteoclast co-culture system","volume":"13","author":"Kang","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","article-title":"Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells","volume":"73","author":"Jacques","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1145","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI23738","article-title":"Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis","volume":"115","author":"Lories","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.rdc.2012.08.003","article-title":"Pathophysiology of new bone formation and ankylosis in spondyloarthritis","volume":"38","author":"Lories","year":"2012","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1155","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3899\/jrheum.100200","article-title":"Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis","volume":"37","author":"Chen","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1160","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/art.11389","article-title":"Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis","volume":"48","author":"Lories","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.27231","article-title":"Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis","volume":"62","author":"Daoussis","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1170","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/annrheumdis-2011-200216","article-title":"High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis","volume":"71","author":"Heiland","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1175","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00296-011-1981-0","article-title":"Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy","volume":"32","author":"Kwon","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1180","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.7754\/Clin.Lab.2014.131119","article-title":"Serum functional dickkopf-1 levels are inversely correlated with radiographic severity of ankylosing spondylitis","volume":"60","author":"Yucong","year":"2014","journal-title":"Clin. Lab."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1185","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/art.24888","article-title":"Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis","volume":"60","author":"Appel","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semcdb.2015.10.013_bib1190","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1186\/ar4096","article-title":"Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors","volume":"14","author":"Haynes","year":"2012","journal-title":"Arthritis Res. Ther."}],"container-title":["Seminars in Cell &amp; Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952115002104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952115002104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T16:22:41Z","timestamp":1572452561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952115002104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":119,"alternative-id":["S1084952115002104"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2015.10.013","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mediators of inflammation and bone remodeling in rheumatic disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2015.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}